当前您的位置: 首页 > 英文站 > Research Support > Core Facilities > Cores > Drug Screening Core
Research Support
Drug Screening Core
Drug Screening Core provides molecule design, screen and optimization for drug development, as well as tailored treatment relevant to personalized medicine in clinic practice, with a particular focus on oncology, cardiovascular and metabolic diseases. Equipped with a variety of target-specific compounds library, and self-designed automat- ed drug screening workstations, our core routinely conducts comprehensive drug optimi- zation and evaluation. With integrated systems pharmacology, structure-based parallel medicinal and computational chemistry technology, we are able to perform drug development research at the molecular, cellular and orgasm levels. Meanwhile, we use target-known compounds as chemical probes to decipher disease-related signaling pathways.

Director: Zhang Jianming
Automated Drug Screening
Key Equipment: Automatic liquid handler, ultrasensitive microplate detection system, multi parameter high-content analysis system.
Services:
High throughput screening on biochemical at cellular and model organism level
Custom-made compound library
Drug Optimization
Key Equipment: High diversity compound library, Virtual screening system, Medicinal chemistry.
Services:
Synthesis of organic compound/probe
lead compound optimization
patent application
Preclinical Efficacy Evaluation
Key Equipment: Custom protein expression and purification system, molecular interaction analyz- er, cell and tissue culture system.
Services:
Pharmacokinetic and pharmacodynamics evaluation
Preclinical Efficacy Evaluation
Key Equipment: High performance liquid chromatography, high resolution mass spectrometer, nucle- ar magnetic resonance spectrometer.
Services:
Drug analysis
pharmacology and toxicology research
DMPK
Identification of metabolites

Contact
Zhang Qianqian
Email: zhangqianmengjie@outlook.com